Cytomx Therapeutics, Inc. · NASDAQ:CTMX
BlackRock, Inc. reported a 7.60% stake in Cytomx Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 7.60% stake in Cytomx Therapeutics, Inc., 16,551,452 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 16,551,452
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.60% | 16,551,452 |
Source
Related
- Cytomx Therapeutics, Inc.
- BlackRock, Inc.
- Cytomx Therapeutics, Inc. shareholders
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026